MedTech Industry Dynamics
MedTech Industry Dynamics
BD has announced a landmark partnership with the U.S. Government to expand domestic manufacturing and strengthen supply chain resilience for essential medical consumables used in approximately 90% of U.S. hospital visits, including a planned $19 billion investment in the U.S. over several years.
Read MoreBD has appointed Ferass Abuzaina as Worldwide President of its Surgery business unit, effective immediately, where he will drive global strategic, operational, and commercial performance and report to Peter Menziuso, Executive Vice President and President of the Interventional segment.
Read MoreBD is celebrating 70 years of manufacturing at its Sandy, Utah site, a 650,000-square-foot facility employing more than 1,000 people that produces hundreds of millions of peripheral IV catheters and billions of molded components annually for healthcare systems worldwide.
Read MoreBD has named Arthur Hu as Executive Vice President and Chief Information and Digital Officer, effective September 30, bringing more than 25 years of experience in global technology, digital, and business transformation from Lenovo and McKinsey & Company.
Read MoreBD has obtained CE Mark approval for the Revello vascular covered stent, a next-generation device designed to treat atherosclerotic lesions in the iliac arteries and expand endovascular treatment options for peripheral artery disease across Europe.
Read MoreBD has expanded its European molecular diagnostics portfolio after securing IVDR certification for two VIASURE assays, developed with Certest Biotec, for use on the fully automated BD MAX system.
Read MoreBD has launched an IVDR-certified HPV self-collection solution for use outside the United States, enabling at-home sample collection and fully automated lab processing through the BD COR System.
Read MoreBD has introduced the BD Incada Connected Care Platform alongside its revamped Pyxis Pro dispensing system, combining AI-enabled analytics with unified device connectivity to improve visibility and decision-making in medication management.
Read MoreBD has enrolled the first patient in its XTRACT Registry, a multicenter U.S. study designed to assess real-world outcomes of the Rotarex Catheter System for treating peripheral artery disease (PAD).
Read MoreBD’s Suzhou facility begins mass production of the BD FACSLyric, marking a milestone in localized high-end medical device manufacturing in China.
Read More
